Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.

[1]  Da-ping Yu,et al.  CiRS‐7 targeting miR‐7 modulates the progression of non‐small cell lung cancer in a manner dependent on NF‐κB signalling , 2018, Journal of cellular and molecular medicine.

[2]  Yuanlin Ding,et al.  Overexpression of Circular RNA ciRS‐7 Abrogates the Tumor Suppressive Effect of miR‐7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway , 2018, Journal of cellular biochemistry.

[3]  Z. Mei,et al.  microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. , 2017, Cancer letters.

[4]  P. Bie,et al.  Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. , 2017, Cancer letters.

[5]  G. Ercan,et al.  Pancreatic Cancer Stem Cells and Therapeutic Approaches. , 2017, Anticancer research.

[6]  I. Maruyama,et al.  Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model” , 2017, Cells.

[7]  W. Jiang,et al.  MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells , 2017, British Journal of Cancer.

[8]  Peng Zhang,et al.  MiR-129-5p Inhibits Proliferation and Invasion of Chondrosarcoma Cells by Regulating SOX4/Wnt/β-Catenin Signaling Pathway , 2017, Cellular Physiology and Biochemistry.

[9]  C. Qian,et al.  Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression , 2017, Hepatology.

[10]  Laising Yen,et al.  Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. , 2017, Cancer research.

[11]  Yongqiang Chen,et al.  EGFR Family Members’ Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer , 2017, Cancers.

[12]  Wenbo Wang,et al.  Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells , 2017, Oncotarget.

[13]  L. Teimoori-Toolabi,et al.  Molecular alterations contributing to pancreatic cancer chemoresistance. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[14]  Qizhan Liu,et al.  Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[15]  Toshiyoshi Fujiwara,et al.  Circular RNA ciRS-7—A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer , 2017, Clinical Cancer Research.

[16]  Rogerio Margis,et al.  Circular RNAs are miRNA sponges and can be used as a new class of biomarker. , 2016, Journal of biotechnology.

[17]  Lu Yang,et al.  GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway. , 2016, Oncology reports.

[18]  Kai-yao Hua,et al.  MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. , 2016, International journal of oncology.

[19]  W. Weichert,et al.  Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the Seed , 2016, Pancreas.

[20]  Xudong Wang,et al.  microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer. , 2016, Molecular medicine reports.

[21]  K. Xie,et al.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer , 2016, Clinical Cancer Research.

[22]  Jun Li,et al.  miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways , 2016, Oncotarget.

[23]  H. Xie,et al.  Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer , 2016, Oncotarget.

[24]  Y. Matsuno,et al.  Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma , 2016, PloS one.

[25]  J. Satayavivad,et al.  Chlorpyrifos promotes colorectal adenocarcinoma H508 cell growth through the activation of EGFR/ERK1/2 signaling pathway but not cholinergic pathway. , 2015, Toxicology.

[26]  Tengteng Zhang,et al.  Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and invasion in gastric cancer. , 2015, International journal of clinical and experimental medicine.

[27]  A. Biankin,et al.  The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling , 2015, Molecular Cancer.

[28]  Dong Shik Lee,et al.  EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma. , 2015, International journal of clinical and experimental pathology.

[29]  T. Fujii,et al.  MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. , 2015, Carcinogenesis.

[30]  Huadan Xue,et al.  Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma , 2015, PloS one.

[31]  W. Di,et al.  MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer , 2014, PloS one.

[32]  Zhen-lin Liu,et al.  miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways. , 2014, International journal of oncology.

[33]  J. Kjems,et al.  Circular RNA and miR-7 in cancer. , 2013, Cancer research.

[34]  Hua-Chien Chen,et al.  EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. , 2010, Cancer research.

[35]  Liangliang Xu,et al.  The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma , 2016, Journal of Cancer Research and Clinical Oncology.

[36]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.